Distinguishing pseudoprogression from progression in high-grade gliomas: a brief review of current clinical practice and demonstration of the potential value of 18F-FDG PET.

Clinical nuclear medicine

Volumn 38, Issue 5, 2013, Pages 381-384

  Oborski, Matthew J ^a   Laymon, Charles M ^a   Lieberman, Frank S ^a   Mountz, James M ^a  

^a not available ^*

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER GRADING; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; GLIOMA; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING;

DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FLUORODEOXYGLUCOSE F18; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; POSITRON-EMISSION TOMOGRAPHY;

EID: 85027958461     PISSN: None     EISSN: 15360229     Source Type: None    
DOI: None     Document Type: Article

References (0)